Meeting Archive:
How Collaboration Fosters Growth and Minimizes Risk in Emerging Pharmaceutical Markets

Meeting Description:
As a senior leader in pharmaceutical development and manufacturing, you know that keeping up-to-date on industry trends is critical to maintaining competitive edge. But do you know how to actively drive these trends and apply them to your manufacturing processes? Are you collaborating with the right stakeholders in order to expand your capabilities and bring your innovation strategy to life?

Dr. Bala Raghunath, MilliporeSigma’s leading expert on biopharmaceutical purification processes, shares various considerations biopharma companies should factor into their plans to manage risk while expanding their drug pipeline and geographical footprint into emerging markets.

Emerging markets provide tremendous opportunities for growth and expansion of the biopharmaceutical industry. However, this growth also brings potential barriers such as affordability of care, regulatory uncertainty, political instability, availability of skilled workforce to manufacture the drug, and cultural attitudes to new therapeutic modalities.
The presentation will explore:
  • Opportunities and challenges biopharmaceutical companies face when entering and/or expanding in emerging markets
  • The integral role of partnership and the use of M Lab™ Collaboration Centers to explore opportunities, expand geographic footprint and mitigate risk in emerging markets
  • Strategies for using single-use technologies and next generation processing to address emerging market production needs while reducing risk, capital investment, and timelines
Date: Wed, Jun 28, 2017
Time: 11:00 AM EDT
Duration: 15 minutes
Host(s): BioProcess International
 Presenter Information
Bala Raghunath
Speaker Photo

As the global director of global manufacturing sciences and technologies (MSAT) group, Bala leads a team of over 80 engineers and scientists responsible for the development, design and implementation of purification and separation process in the biopharmaceutical industry.

With over 22 years of rich experience in applied separations and an enviable track record of leading and implementing process scale separation projects around the world, Bala offers unique expertise and insights on advanced technologies and practices that are emerging in the domain of biotechnology and pharmaceutical processes.

Bala is a chemical engineer and has a B.Tech degree from the IIT, Mumbai (India), and MS & PhD degrees from the Center-of-Excellence for Membrane Technology at the University of Cincinnati, (USA).  He has been an invited speaker at various technical conferences, has authored two patents and has also published several highly cited papers.